approval
savePYZCHIVA (USTEKINUMAB-TTWE) — FDA approval
community read0 votes
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalNov 18, 2025 · 320d ago
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalNov 18, 2025 · 320d ago
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalJun 27, 2025 · 464d ago
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalApr 30, 2025 · 522d ago
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalApr 30, 2025 · 522d ago
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalApr 30, 2025 · 522d ago
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalMar 13, 2025 · 570d ago
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalMar 13, 2025 · 570d ago
same company · ±60 days · 6
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalJun 28, 2024
- approvalHADLIMA: HADLIMA (ADALIMUMAB-BWWD) — FDA approvalJun 28, 2024
- approvalEPYSQLI: EPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJul 19, 2024
- approvalOPUVIZ: OPUVIZ (AFLIBERCEPT-YSZY) — FDA approvalMay 20, 2024
- approvalETICOVO: ETICOVO (ETANERCEPT-YKRO) — FDA approvalMay 3, 2024
- approvalETICOVO: ETICOVO (ETANERCEPT-YKRO) — FDA approvalMay 3, 2024
comments(0)
5-min edit window · permanent after that